High-Dose Intravenous Immunoglobulin as a Therapeutic Option for Deteriorating Patients With Coronavirus Disease 2019

被引:280
作者
Cao, Wei [1 ]
Liu, Xiaosheng [2 ]
Bai, Tao [3 ]
Fan, Hongwei [1 ]
Hong, Ke [3 ]
Song, Hui [3 ]
Han, Yang [1 ]
Lin, Ling [1 ]
Ruan, Lianguo [3 ]
Li, Taisheng [1 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Infect Dis, 1 Shuai Fu Yuan, Beijing 100730, Peoples R China
[2] Tsinghua Univ, Sch Med, Tsinghua Peking Ctr Life Sci, Beijing, Peoples R China
[3] Jin Yin Tan Hosp, Dept Infect Dis, Wuhan, Peoples R China
来源
OPEN FORUM INFECTIOUS DISEASES | 2020年 / 7卷 / 03期
关键词
coronavirus disease 2019; high-dose intravenous immunoglobulin; immunomodulation; SARS-CoV-2; AUTOIMMUNE; OUTCOMES;
D O I
10.1093/ofid/ofaa102
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The outbreak of coronavirus disease 2019 (COVID-19) has spread rapidly in China. Until now, no definite effective treatment has been identified. We reported on 3 patients with severe COV1D-19 who received high-dose intravenous immunoglobulin (IVIg) with satisfactory recovery. Based on these observations, randomized studies of high-dose IVIg should be considered in deteriorating patients infected with COVID-19. The outbreak of coronavirus disease 2019 (COVID-19) has spread rapidly in China. Until now, no definite effective treatment has been identified. We reported on 3 patients with severe COVID-19 who received high-dose intravenous immunoglobulin (IVIg) with satisfactory recovery. Based on these observations, randomized studies of high-dose IVIg should be considered in deteriorating patients infected with COVID-19.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 16 条
[1]   Clinical Course and Outcomes of Critically Ill Patients With Middle East Respiratory Syndrome Coronavirus Infection [J].
Arabi, Yaseen M. ;
Arifi, Ahmed A. ;
Balkhy, Hanan H. ;
Najm, Hani ;
Aldawood, Abdulaziz S. ;
Ghabashi, Alaa ;
Hawa, Hassan ;
Alothman, Adel ;
Khaldi, Abdulaziz ;
Al Raiy, Basel .
ANNALS OF INTERNAL MEDICINE, 2014, 160 (06) :389-+
[2]  
Chung MS, 2020, EUR RADIOL, V30, P2182, DOI [10.1148/radiol.2020200230, 10.1007/s00330-019-06574-1]
[3]   Intravenous Immunoglobulin in the Treatment of Primary Immunodeficiency Diseases [J].
De Ranieri, Deirdre ;
Fenny, Nana Sarkoah .
PEDIATRIC ANNALS, 2017, 46 (01) :E8-E12
[4]   IVIG-mediated effector functions in autoimmune and inflammatory diseases [J].
Galeotti, Caroline ;
Kaveri, Srini V. ;
Bayry, Jagadeesh .
INTERNATIONAL IMMUNOLOGY, 2017, 29 (11) :491-498
[5]   Intravenous immunoglobulin for adults with autoimmune thrombocytopenic purpura:: results of a randomized trial comparing 0•5 and 1 g/kg bw [J].
Godeau, B ;
Caulier, MT ;
Decuypere, L ;
Rose, C ;
Schaeffer, A ;
Bierling, P .
BRITISH JOURNAL OF HAEMATOLOGY, 1999, 107 (04) :716-719
[6]  
Gurwitz D, DRUG DEV RES
[7]   Advances in the understanding of the mechanism of action of IVIg [J].
Hartung, Hans-Peter .
JOURNAL OF NEUROLOGY, 2008, 255 (Suppl 3) :3-6
[8]   Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China (vol 395, pg 497, 2020) [J].
Huang, C. ;
Wang, Y. ;
Li, X. .
LANCET, 2020, 395 (10223) :496-496
[9]   Respiratory syncytial virus infection in patients with hematological diseases: Single-center study and review of the literature [J].
Khanna, Nina ;
Widmer, Andreas F. ;
Decker, Michael ;
Steffen, Ingrid ;
Halter, Joerg ;
Heim, Dominik ;
Weisser, Maja ;
Gratwohl, Alois ;
Fluckiger, Ursula ;
Hirsch, Hans H. .
CLINICAL INFECTIOUS DISEASES, 2008, 46 (03) :402-412
[10]   Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding [J].
Lu, Roujian ;
Zhao, Xiang ;
Li, Juan ;
Niu, Peihua ;
Yang, Bo ;
Wu, Honglong ;
Wang, Wenling ;
Song, Hao ;
Huang, Baoying ;
Zhu, Na ;
Bi, Yuhai ;
Ma, Xuejun ;
Zhan, Faxian ;
Wang, Liang ;
Hu, Tao ;
Zhou, Hong ;
Hu, Zhenhong ;
Zhou, Weimin ;
Zhao, Li ;
Chen, Jing ;
Meng, Yao ;
Wang, Ji ;
Lin, Yang ;
Yuan, Jianying ;
Xie, Zhihao ;
Ma, Jinmin ;
Liu, William J. ;
Wang, Dayan ;
Xu, Wenbo ;
Holmes, Edward C. ;
Gao, George F. ;
Wu, Guizhen ;
Chen, Weijun ;
Shi, Weifeng ;
Tan, Wenjie .
LANCET, 2020, 395 (10224) :565-574